Condition
Cortisol Overproduction
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05307328Phase 2Completed
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
NCT05523115Not ApplicableCompleted
An Exploratory Investigation of a Supplement to Promote Cognitive Health Benefits
NCT05607706Not ApplicableCompleted
Effect of Maternal Odor and Kangaroo Care on Serum Cortisol and Comfort Levels in Preterm Infants: a Randomised Trial
NCT03919734Completed
Morbidity and Mortality in Autonomous Cortisol Secretion
NCT03830437CompletedPrimary
Salivary Cortisol as Stress Marker in Newborns Subjected to Double Weighing With Physiological Body Weight
Showing all 5 trials